Federated Hermes’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-21,674
| Closed | -$2.15M | – | 2385 |
|
|
2019
Q3 | $2.15M | Sell |
21,674
-570
| -3% | -$54.2K | 0.01% | 1013 |
|
|
2019
Q2 | $2.06M | Sell |
22,244
-5,548
| -20% | -$527K | 0.01% | 1046 |
|
|
2019
Q1 | $2.62M | Sell |
27,792
-152,824
| -85% | -$13.4M | 0.01% | 954 |
|
|
2018
Q4 | $11.6M | Sell |
180,616
-124,354
| -41% | -$9.18M | 0.03% | 443 |
|
|
2018
Q3 | $27.3M | Buy |
304,970
+27,284
| +10% | +$2.41M | 0.06% | 290 |
|
|
2018
Q2 | $22.1M | Buy |
277,686
+48,315
| +21% | +$4.01M | 0.06% | 229 |
|
|
2018
Q1 | $20.5M | Buy |
229,371
+10,404
| +5% | +$999K | 0.06% | 244 |
|
|
2017
Q4 | $22.9M | Sell |
218,967
-29
| -0% | -$3.27K | 0.06% | 228 |
|
|
2017
Q3 | $31.9M | Sell |
218,996
-659
| -0.3% | -$89.8K | 0.09% | 191 |
|
|
2017
Q2 | $28.5M | Buy |
219,655
+19,873
| +10% | +$2.44M | 0.08% | 213 |
|
|
2017
Q1 | $24.9M | Buy |
199,782
+102,775
| +106% | +$12.3M | 0.07% | 234 |
|
|
2016
Q4 | $11.2M | Sell |
97,007
-19,521
| -17% | -$2.17M | 0.03% | 389 |
|
|
2016
Q3 | $12.2M | Sell |
116,528
-6,897
| -6% | -$746K | 0.04% | 384 |
|
|
2016
Q2 | $12.2M | Buy |
123,425
+3,478
| +3% | +$360K | 0.04% | 382 |
|
|
2016
Q1 | $12M | Sell |
119,947
-4,637
| -4% | -$477K | 0.04% | 385 |
|
|
2015
Q4 | $14.9M | Buy |
124,584
+42,165
| +51% | +$4.88M | 0.05% | 344 |
|
|
2015
Q3 | $8.92M | Buy |
82,419
+4,491
| +6% | +$557K | 0.03% | 458 |
|
|
2015
Q2 | $9.02M | Buy |
77,928
+6,832
| +10% | +$781K | 0.03% | 479 |
|
|
2015
Q1 | $8.2M | Sell |
71,096
-91,164
| -56% | -$10.9M | 0.03% | 500 |
|
|
2014
Q4 | $18.2M | Buy |
162,260
+71,688
| +79% | +$7.56M | 0.06% | 312 |
|
|
2014
Q3 | $8.59M | Sell |
90,572
-48,615
| -35% | -$4.39M | 0.03% | 492 |
|
|
2014
Q2 | $12M | Sell |
139,187
-20,083
| -13% | -$1.53M | 0.04% | 410 |
|
|
2014
Q1 | $11.1M | Sell |
159,270
-224
| -0.1% | -$17.7K | 0.04% | 435 |
|
|
2013
Q4 | $13.5M | Sell |
159,494
-43,872
| -22% | -$3.47M | 0.05% | 367 |
|
|
2013
Q3 | $15.7M | Buy |
203,366
+74,658
| +58% | +$5.23M | 0.06% | 272 |
|
|
2013
Q2 | $7.52M | Buy |
+128,708
| New | +$7.75M | 0.03% | 446 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Federated Hermes's CELG Position: Q4 2019 in Review
Federated Hermes sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 21,674 shares — an estimated $2.15M sold.
Federated Hermes first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $31.9M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Federated Hermes reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Federated Hermes sold 21,674 Celgene Corp shares in Q4 2019, an estimated $2.15M.
- Federated Hermes first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Federated Hermes's Celgene Corp position peaked at $31.9M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Federated Hermes's 13F filing for Q4 2019, filed 14 Feb 2020.